SCHEMBL3315413

SCHEMBL3315413

O=C(O)/C(O)=C\C(=O)c1ccc(F)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.41
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CES2 O00748 3/20 0.40
CES1 P23141 3/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
F2R P25116 1/20 0.37
KEAP1 Q14145 1/20 0.37
MAOB P27338 3/20 0.36
ACHE P22303 1/20 0.35
BACE1 P56817 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3315407 1.00 PKM (0.41) PKMMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL3315416 1.00 PKM (0.41) PKMMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL3312422 0.84 CES2 (0.55) NPC1RAB9ACES2CES1ALDH1A1
SCHEMBL3312433 0.84 CES2 (0.55) NPC1RAB9ACES2CES1ALDH1A1
SCHEMBL3312430 0.84 CES2 (0.55) NPC1RAB9ACES2CES1ALDH1A1
SCHEMBL3312859 0.83 MAPT (0.40) PKMMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL3312856 0.83 MAPT (0.40) PKMMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL13424979 0.81 CES2 (0.39) MAPTCES2CES1KEAP1MAOB
SCHEMBL3310538 0.81 CES2 (0.55) CES2CES1ALDH1A1KEAP1MAOB
SCHEMBL3310540 0.81 CES2 (0.55) CES2CES1ALDH1A1KEAP1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 PKM 379/4885MAPT 1964/4885NPC1 2680/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 PKM 379/4885MAPT 1964/4885NPC1 2680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.